Bentec Medical Revenue and Competitors
Estimated Revenue & Valuation
- Bentec Medical's estimated annual revenue is currently $8M per year.
- Bentec Medical's estimated revenue per employee is $251,000
Employee Data
- Bentec Medical has 32 Employees.
- Bentec Medical grew their employee count by -6% last year.
Bentec Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder | Reveal Email/Phone |
Bentec Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Bentec Medical?
Bentec Medical specializes in custom silicone fabrication, with expertise in molding, extrusion, calendaring, casting and assembly of complex high-performance medical device components. Fully integrated from concept to completion, we leverage our material science knowledge and manufacturing capabilities to provide the highest quality products, consistently, timely and cost effectively to our OEM partners. Bentec products are made for use in Oncology, Cardiology, Urology, Pediatrics, Bariatric, General & Cosmetic Surgery, ENT, and Interventional Radiology.
keywords:N/AN/A
Total Funding
32
Number of Employees
$8M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bentec Medical News
... Inc., Bentec Medical OpCo LLC, Rogers Corporation, ALLERGAN, ELMET TECHNOLOGIES, Cabot Corporation, Marsh Bellofram Group of Companies,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 32 | 10% | N/A |
#2 | $4.8M | 34 | 10% | N/A |
#3 | $5M | 35 | -15% | N/A |
#4 | $300M | 43 | 2% | N/A |
#5 | $7.5M | 43 | -2% | N/A |